BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ali NM, Alnazari N, Mehta SA, Boyarsky B, Avery RK, Segev DL, Montgomery RA, Stewart ZA. Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination. Transplantation 2021. [PMID: 34049360 DOI: 10.1097/TP.0000000000003836] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Peluso MJ, Munter SE, Lynch KL, Yun C, Torres L, Iyer NS, Donatelli J, Ryan L, Deitchman AN, Deeks SG, Rutishauser RL, Henrich TJ. Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease. Open Forum Infect Dis 2021;8:ofab393. [PMID: 34395717 DOI: 10.1093/ofid/ofab393] [Reference Citation Analysis]
2 Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, Lerma EV, Suri RS, Topf J, Willicombe M, Hiremath S. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD. Kidney Int Rep 2021;6:2292-304. [PMID: 34250319 DOI: 10.1016/j.ekir.2021.06.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Alberca RW, Benard G, Alberca GGF, Sato MN. SARS-CoV-2 infection in liver transplant recipients: A complex relationship. World J Gastroenterol 2021; 27(44): 7734-7738 [PMID: 34908810 DOI: 10.3748/wjg.v27.i44.7734] [Reference Citation Analysis]
4 Peled Y, Ram E, Lavee J, Segev A, Matezki S, Wieder-Finesod A, Halperin R, Mandelboim M, Indenbaum V, Levy I, Sternik L, Raanani E, Afek A, Kreiss Y, Lustig Y, Rahav G. Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience. J Heart Lung Transplant 2021:S1053-2498(21)02481-5. [PMID: 34565682 DOI: 10.1016/j.healun.2021.08.010] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Werbel WA, Boyarsky BJ, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med 2021. [PMID: 34125572 DOI: 10.7326/L21-0282] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 34.0] [Reference Citation Analysis]
6 Kute V, Meshram HS, Sharma A, Chaudhury AR, Sudhindran S, Gokhale AK, Hote M, Guleria R, Rana DS, Prakash J, Ramesh V. Update on Coronavirus 2019 Vaccine Guidelines for Transplant Recipients. Transplant Proc 2021:S0041-1345(21)00683-7. [PMID: 34690000 DOI: 10.1016/j.transproceed.2021.09.007] [Reference Citation Analysis]
7 Stainer A, Amati F, Suigo G, Simonetta E, Gramegna A, Voza A, Aliberti S. COVID-19 in Immunocompromised Patients: A Systematic Review. Semin Respir Crit Care Med 2021;42:839-58. [PMID: 34918325 DOI: 10.1055/s-0041-1740110] [Reference Citation Analysis]
8 Fernández-Ruiz M, Almendro-Vázquez P, Carretero O, Ruiz-Merlo T, Laguna-Goya R, San Juan R, López-Medrano F, García-Ríos E, Más V, Moreno-Batenero M, Loinaz C, Andrés A, Pérez-Romero P, Paz-Artal E, Aguado JM. Discordance Between SARS-CoV-2-specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients. Transplant Direct 2021;7:e794. [PMID: 34805496 DOI: 10.1097/TXD.0000000000001246] [Reference Citation Analysis]
9 Loconsole D, Stea ED, Sallustio A, Fontò G, Pronzo V, Simone S, Centrone F, Accogli M, Gesualdo L, Chironna M. Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients. Vaccines (Basel) 2021;9:806. [PMID: 34451931 DOI: 10.3390/vaccines9080806] [Reference Citation Analysis]
10 Russo G, Lai Q, Poli L, Perrone MP, Gaeta A, Rossi M, Mastroianni CM, Garofalo M, Pretagostini R. SARS-COV-2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications. Clin Transplant 2021;:e14495. [PMID: 34569101 DOI: 10.1111/ctr.14495] [Reference Citation Analysis]
11 Sgherza N, Curci P, Rizzi R, Attolico I, Loconsole D, Mestice A, Chironna M, Musto P. SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma. Blood Cancer J 2021;11:201. [PMID: 34907155 DOI: 10.1038/s41408-021-00597-y] [Reference Citation Analysis]
12 Stock PG, Henrich TJ, Segev DL, Werbel WA. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients. J Clin Invest 2021;131:151178. [PMID: 34143755 DOI: 10.1172/JCI151178] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Bestard O, Jouve T, Castells L, Lopez M, Muñoz M, Crespo E, Toapanta N, Esperalba J, Campos-Varela I, Pont T, Len O, Campins M, Moreso F. Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients. Am J Transplant 2021. [PMID: 34554648 DOI: 10.1111/ajt.16855] [Reference Citation Analysis]
14 Marion O, Del Bello A, Abravanel F, Faguer S, Esposito L, Laure Hebral A, Bellière J, Izopet J, Kamar N. Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients. Transplant Direct 2022;8:e1248. [PMID: 34966837 DOI: 10.1097/TXD.0000000000001248] [Reference Citation Analysis]
15 Yılmaz EA, Özdemir Ö. Solid organ transplantations and COVID-19 disease. World J Transplant 2021; 11(12): 503-511 [DOI: 10.5500/wjt.v11.i12.503] [Reference Citation Analysis]